Argenica Therapeutics LtdASX: AGN

Positive Preclinical Data for ARG-007 Neuroprotection in HIE

· Issued by Argenica Therapeutics Ltd

Filed with ASX · · 6 pages · English

• ARG-007 shown to offer neuroprotection for late pre-term hypoxic-ischaemic encephalopathy (HIE), providing further evidence that the technology could have greater applications beyond stroke. • HIE is a type of brain dysfunction that occurs when the brain doesn't receive enough oxygen or blood flow for a period of time. It is one of the most serious birth complications for infants. • In an animal

Argenica Therapeutics Ltd on 6ix

Earlier from Argenica Therapeutics

Later from Argenica Therapeutics

All Argenica Therapeutics news releases